Effects of endothelin-1 on the relaxation of rat coronary arteries

J Cardiovasc Pharmacol. 2009 Nov;54(5):445-50. doi: 10.1097/FJC.0b013e3181bae3f0.

Abstract

To analyze the effects of endothelin-1 on the b-adrenergic response of the coronary circulation, 2-mm-long segments of coronary arteries from rats were prepared for isometric tension recording in organ baths. The relaxation to isoproterenol (3 x 10(-8) M), field electrical stimulation (4 Hz, 0.1-millisecond duration, 10 seconds), acetylcholine (3 x 10(-8) M), and sodium nitroprusside (10(-9) M) was recorded in arteries precontracted with U46619 (10(-7) to 5 x 10(-7) M) before and after treatment with endothelin-1 (3 3 10210 and 1029 M). The relaxation to isoproterenol was increased by treatment with endothelin-1 and with the endothelin ET(B) antagonist BQ788 (10(-6) M) but not with the endothelin ET(A) antagonist BQ123 (10(-6) M) or with the blocker of protein kinase C chelerythrine (10(-5) M). In the presence of BQ788, BQ123, or chelerythrine, endothelin-1 did not modify the relaxation to isoproterenol. Treatment with endothelin-1 did not modify the relaxation to electrical stimulation, acetylcholine, or sodium nitroprusside. These results suggest that endothelin-1 may potentiate coronary beta-adrenergic vasodilatation, at least in part due to stimulation of endothelin ET(A) receptors and activation of protein kinase C.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Coronary Vessels / drug effects*
  • Endothelin-1 / pharmacology*
  • In Vitro Techniques
  • Isometric Contraction / drug effects
  • Isoproterenol / pharmacology
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Thromboxane A2 / analogs & derivatives
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*

Substances

  • Adrenergic beta-Agonists
  • Endothelin-1
  • Vasoconstrictor Agents
  • Thromboxane A2
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Isoproterenol